ACGN
Aceragen, Inc.

46
Mkt Cap
$3.2M
Volume
0.00
52W High
$16.00
52W Low
$0.3601
PE Ratio
-0.07
ACGN Fundamentals
50D MA
$1.06
Beta
0.49
Avg. Volume
128,092.10
P/B
0.06
Loading...
Loading...
Aceragen, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the research and development of medications for rare and orphan diseases. The firm's product portfolio includes ACG-801 and ACG-701, which targets Farber Disease, Melioidosis, and Cystic Fibrosis. The company was founded in 1989 and is headquartered in Durham, NC.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Aceragen Inc?
What is the 52-week high for Aceragen Inc?
What is the 52-week low for Aceragen Inc?
What is the PE ratio of Aceragen Inc?
What is the Price-to-Book ratio of Aceragen Inc?
What is the 50-day moving average of Aceragen Inc?

Latest ACGN News

View
No ACGN news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.